Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
$651M |
| 2 |
Monster Beverage
MNST
|
$615M |
| 3 |
Intercontinental Exchange
ICE
|
$556M |
| 4 |
Johnson & Johnson
JNJ
|
$382M |
| 5 |
Applied Materials
AMAT
|
$381M |
Top Sells
| 1 |
Lam Research
LRCX
|
$1.95B |
| 2 |
Texas Instruments
TXN
|
$771M |
| 3 |
Deere & Co
DE
|
$597M |
| 4 |
Meta Platforms (Facebook)
META
|
$543M |
| 5 |
Microsoft
MSFT
|
$510M |
Sector Composition
| 1 | Technology | 34.01% |
| 2 | Healthcare | 19.85% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.48% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Avidity Biosciences
RNA
$6.24B
| $225M | 0.12% |
4,896,166
+1,239,323
| +34% | +$56.9M |
|
177
General Dynamics
GD
$86.7B
| $223M | 0.11% |
737,105
-316,457
| -30% | -$95.6M |
|
178
Core & Main
CNM
$12.5B
| $223M | 0.11% |
5,015,867
-27,862
| -0.6% | -$1.24M |
|
179
Burlington
BURL
$19B
| $222M | 0.11% |
842,188
-239,957
| -22% | -$63.2M |
|
180
Amphenol
APH
$138B
| $217M | 0.11% |
3,323,021
-23,081
| -0.7% | -$1.5M |
|
181
Vanguard S&P 500 ETF
VOO
$730B
| $214M | 0.11% |
406,460
-23,953
| -6% | -$12.6M |
|
182
Sotera Health
SHC
$4.4B
| $212M | 0.11% |
12,668,790
-1,824,046
| -13% | -$30.5M |
|
183
Zai Lab
ZLAB
$3.34B
| $211M | 0.11% |
8,760,074
+2,232,507
| +34% | +$53.9M |
|
184
Ryan Specialty Holdings
RYAN
$7.04B
| $209M | 0.11% |
3,148,916
+13,986
| +0.4% | +$929K |
|
185
Walker & Dunlop
WD
$2.84B
| $209M | 0.11% |
1,836,529
+502
| +0% | +$57K |
|
186
Wayfair
W
$10.7B
| $207M | 0.11% |
3,691,462
+327,944
| +10% | +$18.4M |
|
187
Soleno Therapeutics
SLNO
$3.7B
| $206M | 0.11% |
4,081,099
+722,226
| +22% | +$36.5M |
|
188
Goldman Sachs
GS
$227B
| $205M | 0.11% |
414,867
+251,972
| +155% | +$125M |
|
189
Akero Therapeutics
AKRO
$3.52B
| $203M | 0.1% |
7,077,478
+201,225
| +3% | +$5.77M |
|
190
Elevance Health
ELV
$69.4B
| $201M | 0.1% |
386,404
-1,731
| -0.4% | -$900K |
|
191
IBM
IBM
$230B
| $193M | 0.1% |
871,064
+183,141
| +27% | +$40.5M |
|
192
Microchip Technology
MCHP
$34.8B
| $191M | 0.1% |
2,384,306
-1,122,219
| -32% | -$90.1M |
|
193
Palo Alto Networks
PANW
$129B
| $191M | 0.1% |
1,115,550
+179,438
| +19% | +$30.7M |
|
194
Coca-Cola
KO
$294B
| $190M | 0.1% |
2,648,552
-101,657
| -4% | -$7.3M |
|
195
Motorola Solutions
MSI
$79.7B
| $188M | 0.1% |
419,161
-7,675
| -2% | -$3.45M |
|
196
Bristol-Myers Squibb
BMY
$95B
| $184M | 0.09% |
3,554,758
+3,107,672
| +695% | +$161M |
|
197
OSI Systems
OSIS
$3.97B
| $184M | 0.09% |
1,209,168
+29,858
| +3% | +$4.53M |
|
198
Sensient Technologies
SXT
$4.79B
| $179M | 0.09% |
2,231,803
+2,053
| +0.1% | +$165K |
|
199
Surgery Partners
SGRY
$2.87B
| $177M | 0.09% |
5,497,368
+1,184,450
| +27% | +$38.2M |
|
200
Realty Income
O
$53.3B
| $175M | 0.09% |
2,760,182
+2,675,266
| +3,150% | +$170M |
|